Cargando…
Distribution of CYP2B6 516G/T pharmacogenetically important polymorphism in the Ukrainian population
The CYP2B6 is one of the members of the cytochrome P450 superfamily. This enzyme metabolizes a number of currently prescribed drugs and different compounds. In light of clinical significance of the CYP2B6∗6 variant of the CYP2B6 gene, the aim of this study was to investigate the distribution of one...
Autores principales: | Filiptsova, Olga, Kobets, Marina, Kobets, Julia, Naboka, Olga, Koiro, Olga, Ochkur, Alexandr, Galiy, Larisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035515/ https://www.ncbi.nlm.nih.gov/pubmed/29991909 http://dx.doi.org/10.1016/j.jsps.2018.02.027 |
Ejemplares similares
-
Population Study of Fears in Two Generations of Ukrainians
por: Filiptsova, O. V., et al.
Publicado: (2015) -
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV‐associated hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2019) -
An Unusual Presentation of Iron-Deficiency Anemia: An Autobiographical Case Report
por: Kobets, Andrew, et al.
Publicado: (2021) -
The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities
por: Daraki, Aggeliki, et al.
Publicado: (2014) -
The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)